News for Immunic, Inc. (IMUX)

**media[600316,600317,600318,600319,600320,600321]**

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipe

PR NewswireNEW YORK, Feb. 26, 2025 ”“ Vidofludimus Calcium's Activation of Nurr1 Reduces Neuronal Loss and Injury Directly and Indirectly By Decreasing Mi

On December 31, 2024, JANUS HENDERSON GROUP PLC (Trades, Portfolio) executed a significant transaction involving the reduction of its holdings in Immunic Inc (I

Overview of the Recent Transaction On December 31, 2024, Avidity Partners Management LP (Trades, Portfolio) made a significant move by acquiring an additional 7

PR NewswireNEW YORK, Jan. 7, 2025 ”“ Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April

PR NewswireNEW YORK, Nov. 26, 2024 NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pip

Immunic, Inc. (NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Vice President Investor Relations...

Release Date: November 07, 2024For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Immunic Inc

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NIMUX.OQ - Immunic IncQ3 2024 Immunic Inc Earnings CallNov 07, 2024 / 01:00PM GMT =============

The following slide deck was published by Immunic, Inc.

Immunic to Participate in Industry, Scientific and Investor Conferences in November

Texas-based Genprex, Inc. (GNPX), a clinical-stage gene therapy company is up over 103 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Cash and Cash Equivalents: $79.7 million as of June 30, 2024.R&D Expenses: $18.3 million for Q2 2024, down from $21.2 million in Q2 2023.G&A Expenses: $4.5 mil

Aug 08, 2024 / 12:00PM GMTJessica Breu - Immunic Inc - Head of Investor Relations and Communications Good morning, and welcome to Immunic second-quarter 2024 ea

Canada-based Versus Systems Inc. (VS) is up over 80 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.

Moonlake is an intriguing investment opportunity in the inflammatory disease space. Click here to read my thoughts on MLTX stock and its catalysts.